Registry for patients with endocrine tumors undergoing surgery
Official title: Registre Tumeurs Endocrine - Eurocrine
Run by Central Hospital, Nancy, France · NCT03410394 · Data updated 2026-11-12
This study is collecting information from patients with endocrine tumors who are having surgery to help improve treatment and care for these rare conditions across Europe.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 3000 (estimated) |
| Sponsor | Central Hospital, Nancy, France Academic / other |
| Locations | 1 site (Vandœuvre-lès-Nancy) |
| Status | Recruiting |
| Started | January 1, 2015 |
| Main results expected | January 1, 2030 |
| Study ends | January 1, 2030 |
| Registry record updated | October 22, 2026 |
| Trial ID | NCT03410394 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this registry are patients undergoing surgical procedures for endocrine tumors at the University Nancy Brabois Hospital.
✕Probably not a fit
Patients who are unable to provide informed consent or refuse to participate will not benefit from this registry.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This registry collects data on patients with endocrine tumors, including those affecting the thyroid, parathyroid, adrenal glands, endocrine pancreas, and digestive tube, who are undergoing surgical procedures. It is part of the Eurocrine Project, which aims to create a pan-European database to improve the understanding and treatment of these rare tumors. By recording and analyzing data at a European level, the project seeks to enhance clinical standards and reduce variations in practice across different clinics and countries. The ultimate goal is to decrease morbidity and mortality associated with these rare endocrine tumors through improved knowledge and practices.
Why it matters
Potential benefit: If successful, this registry could lead to improved diagnosis and treatment protocols for patients with rare endocrine tumors.
How similar studies have gone: Other studies have shown success in utilizing registries to improve outcomes for rare conditions, making this approach promising.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * patients who undergo surgical procedures for endocrine tumors at the University Nancy Brabois Hospital Exclusion Criteria: * unable to receive clear information * refusal to sign the consent form
Where it's running
-
CHU Nancy
Vandœuvre-lès-Nancy, France Recruiting
Study contacts
- Principal investigator: laurent Brunaud — University of Lorraine
- Study coordinator: laurent Brunaud, MD, PhD
- Email: l.brunaud@chru-nancy.fr
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Methionine-Reduced Diet in Solid Tumors (early-phase)
A small pilot study will test whether a methionine-reduced diet can change blood levels in adults with various solid tumors who are receiving standard cancer therapy.
-
Registry for aggressive pituitary tumors
This study is collecting information on aggressive pituitary tumors to help doctors better understand and manage these cases for patients.
-
Eating disorders in people with phenylketonuria
This study looks at whether eating disorders and BMI issues are more common in people with phenylketonuria who are followed at a French hospital.
-
Piperacillin Prophylaxis in Major Liver and Pancreatic Surgery
This study tests whether piperacillin/tazobactam given around surgery reliably reaches the right levels to help prevent infections in adults undergoing major liver or pancreatic surgery.
-
Real-time CLE imaging to speed and improve lung cancer diagnosis
This project will try to see if using confocal laser endomicroscopy (CLE) during bronchoscopic biopsy can diagnose non-small cell lung cancer faster and with fewer or safer biopsies for people with suspected lung tumors.
-
Comparing the 2024 and 2017 McDonald rules for diagnosing multiple sclerosis
This study will test whether the 2024 McDonald rules diagnose more people with MS at their first neurology visit than the 2017 rules for patients with a first clinical or radiological event suggestive of MS.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.